720 filings
Page 10 of 36
8-K
TENX
Tenax Therapeutics Inc
7 Apr 21
Departure of Directors or Certain Officers
4:45pm
10-K
2020 FY
TENX
Tenax Therapeutics Inc
Annual report
31 Mar 21
4:31pm
8-K/A
TENX
Tenax Therapeutics Inc
30 Mar 21
Financial Statements and Exhibits
4:53pm
SEC STAFF
TENX
Tenax Therapeutics Inc
29 Mar 21
SEC staff action: Order
12:00am
8-K
TENX
Tenax Therapeutics Inc
2 Mar 21
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development
8:36am
SEC STAFF
TENX
Tenax Therapeutics Inc
1 Mar 21
SEC staff action: Order
12:00am
SC 13G/A
Hudson Bay Capital Management LP
11 Feb 21
TENAX THERAPEUTICS / Hudson Bay Capital Management ownership change
12:00am
SC 13G/A
Renaissance Technologies LLC
11 Feb 21
TENAX THERAPEUTICS / RENAISSANCE TECHNOLOGIES ownership change
12:00am
4
Stuart Rich
27 Jan 21
TENAX THERAPEUTICS / Stuart Rich ownership change
4:33pm
3
Stuart Rich
27 Jan 21
TENAX THERAPEUTICS / Stuart Rich ownership change
4:30pm
8-K
TENX
Tenax Therapeutics Inc
19 Jan 21
Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med
8:30am
4
Jebsen Michael B
12 Jan 21
TENAX THERAPEUTICS / Michael B Jebsen ownership change
5:02pm
4
TENX
Tenax Therapeutics Inc
12 Jan 21
TENAX THERAPEUTICS / Anthony A DiTonno ownership change
5:02pm
8-K
TENX
Tenax Therapeutics Inc
18 Nov 20
Regulation FD Disclosure
4:17pm
10-Q
2020 Q3
TENX
Tenax Therapeutics Inc
Quarterly report
16 Nov 20
4:16pm
8-K
TENX
Tenax Therapeutics Inc
15 Oct 20
Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation
8:46am
424B3
TENX
Tenax Therapeutics Inc
1 Oct 20
Prospectus supplement
9:13am
EFFECT
TENX
Tenax Therapeutics Inc
1 Oct 20
Notice of effectiveness
12:15am
CORRESP
TENX
Tenax Therapeutics Inc
29 Sep 20
Correspondence with SEC
12:00am
S-3/A
TENX
Tenax Therapeutics Inc
Shelf registration (amended)
11 Sep 20
8:34am